Gohealth Stock Fundamentals
| GOCO Stock | USD 11.90 0.40 3.48% |
GoHealth fundamentals help investors to digest information that contributes to GoHealth's financial success or failures. It also enables traders to predict the movement of GoHealth Stock. The fundamental analysis module provides a way to measure GoHealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GoHealth stock.
At this time, GoHealth's Income Tax Expense is very stable compared to the past year. As of the 25th of November 2024, Non Operating Income Net Other is likely to grow to about 108.7 K, while Tax Provision is likely to drop about 63.6 K. GoHealth | Select Account or Indicator |
GoHealth Company Profit Margin Analysis
GoHealth's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current GoHealth Profit Margin | (0.04) % |
Most of GoHealth's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GoHealth is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
GoHealth Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, GoHealth has a Profit Margin of -0.0432%. This is 100.37% lower than that of the Insurance sector and 100.44% lower than that of the Financials industry. The profit margin for all United States stocks is 96.6% lower than that of the firm.
GoHealth Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GoHealth's current stock value. Our valuation model uses many indicators to compare GoHealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GoHealth competition to find correlations between indicators driving GoHealth's intrinsic value. More Info.GoHealth is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, GoHealth's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GoHealth's earnings, one of the primary drivers of an investment's value.GoHealth Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GoHealth's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GoHealth could also be used in its relative valuation, which is a method of valuing GoHealth by comparing valuation metrics of similar companies.GoHealth is currently under evaluation in profit margin category among its peers.
GoHealth ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GoHealth's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GoHealth's managers, analysts, and investors.Environmental | Governance | Social |
GoHealth Fundamentals
| Return On Equity | -0.16 | ||||
| Return On Asset | -0.0276 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 660.11 M | ||||
| Shares Outstanding | 10.13 M | ||||
| Shares Owned By Insiders | 14.86 % | ||||
| Shares Owned By Institutions | 54.14 % | ||||
| Number Of Shares Shorted | 204.15 K | ||||
| Price To Earning | 25.59 X | ||||
| Price To Book | 0.57 X | ||||
| Price To Sales | 0.40 X | ||||
| Revenue | 734.67 M | ||||
| Gross Profit | 444 M | ||||
| EBITDA | 38.67 M | ||||
| Net Income | (63.26 M) | ||||
| Cash And Equivalents | 215.4 M | ||||
| Cash Per Share | 24.23 X | ||||
| Total Debt | 592.35 M | ||||
| Debt To Equity | 0.97 % | ||||
| Current Ratio | 1.83 X | ||||
| Book Value Per Share | 20.95 X | ||||
| Cash Flow From Operations | 109.14 M | ||||
| Short Ratio | 11.43 X | ||||
| Earnings Per Share | (3.29) X | ||||
| Price To Earnings To Growth | (0.02) X | ||||
| Target Price | 17.67 | ||||
| Number Of Employees | 2.53 K | ||||
| Beta | 1.65 | ||||
| Market Capitalization | 272.58 M | ||||
| Total Asset | 1.5 B | ||||
| Retained Earnings | (420.28 M) | ||||
| Working Capital | 106.43 M | ||||
| Net Asset | 1.5 B |
About GoHealth Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GoHealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GoHealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GoHealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 52.4 M | 55 M | |
| Total Revenue | 734.7 M | 746.5 M | |
| Cost Of Revenue | 159 M | 195.7 M | |
| Stock Based Compensation To Revenue | 0.03 | 0.03 | |
| Sales General And Administrative To Revenue | 0.13 | 0.20 | |
| Capex To Revenue | 0.02 | 0.02 | |
| Revenue Per Share | 79.06 | 75.66 | |
| Ebit Per Revenue | (0.11) | (0.12) |
Pair Trading with GoHealth
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GoHealth position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GoHealth will appreciate offsetting losses from the drop in the long position's value.Moving together with GoHealth Stock
| 0.89 | EHTH | eHealth | PairCorr |
| 0.83 | AON | Aon PLC | PairCorr |
| 0.67 | BRO | Brown Brown Fiscal Year End 27th of January 2025 | PairCorr |
Moving against GoHealth Stock
| 0.78 | ERIE | Erie Indemnity | PairCorr |
| 0.68 | RELI | Reliance Global Group | PairCorr |
| 0.58 | MMC | Marsh McLennan Companies Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.51 | ZBAO | Zhibao Technology Class | PairCorr |
| 0.48 | SLQT | Selectquote Buyout Trend | PairCorr |
The ability to find closely correlated positions to GoHealth could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GoHealth when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GoHealth - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GoHealth to buy it.
The correlation of GoHealth is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GoHealth moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GoHealth moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GoHealth can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out GoHealth Piotroski F Score and GoHealth Altman Z Score analysis. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (3.29) | Revenue Per Share 69.776 | Quarterly Revenue Growth (0.10) | Return On Assets (0.03) |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.